VANGUARD GROUP INC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$13,301,517
-7.9%
341,152
+1.6%
0.00%
Q1 2024$14,449,086
-3.0%
335,635
+3.8%
0.00%
Q4 2023$14,900,180
+63.5%
323,495
+21.2%
0.00%
Q3 2023$9,114,775
-9.4%
266,826
+2.1%
0.00%
Q2 2023$10,062,091
+12.7%
261,353
+4.8%
0.00%
Q1 2023$8,924,380
+17.8%
249,354
+29.8%
0.00%
Q4 2022$7,573,557
+13.3%
192,076
+3.7%
0.00%
Q3 2022$6,686,000
+19.6%
185,192
+0.7%
0.00%
Q2 2022$5,592,000
+11.9%
183,845
+12.5%
0.00%
Q1 2022$4,997,000
+4.3%
163,468
+6.6%
0.00%
Q4 2021$4,792,000
+192.6%
153,366
+43.1%
0.00%
Q3 2021$1,638,000
-15.0%
107,192
+3.6%
0.00%
Q2 2021$1,926,000
+0.7%
103,436
-3.1%
0.00%
Q1 2021$1,912,000
+27.5%
106,795
+9.5%
0.00%
Q4 2020$1,500,000
+42.7%
97,563
+2.8%
0.00%
Q3 2020$1,051,000
-11.6%
94,893
+0.2%
0.00%
Q2 2020$1,189,00094,7430.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders